Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Total Current Liabilities (2019 - 2025)

Historic Total Current Liabilities for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $27.9 million.

  • Strata Critical Medical's Total Current Liabilities rose 254.96% to $27.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.9 million, marking a year-over-year increase of 254.96%. This contributed to the annual value of $22.7 million for FY2024, which is 3596.69% down from last year.
  • Latest data reveals that Strata Critical Medical reported Total Current Liabilities of $27.9 million as of Q3 2025, which was up 254.96% from $26.3 million recorded in Q2 2025.
  • Over the past 5 years, Strata Critical Medical's Total Current Liabilities peaked at $35.5 million during Q4 2023, and registered a low of $1.5 million during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $21.8 million, with a median of $23.2 million in 2023.
  • Per our database at Business Quant, Strata Critical Medical's Total Current Liabilities surged by 317105.79% in 2021 and then tumbled by 3596.69% in 2024.
  • Strata Critical Medical's Total Current Liabilities (Quarter) stood at $12.8 million in 2021, then soared by 108.14% to $26.6 million in 2022, then skyrocketed by 33.39% to $35.5 million in 2023, then plummeted by 35.97% to $22.7 million in 2024, then rose by 22.65% to $27.9 million in 2025.
  • Its last three reported values are $27.9 million in Q3 2025, $26.3 million for Q2 2025, and $21.9 million during Q1 2025.